Estradiol levels predict short-term adverse health outcomes in postmenopausal acute stroke women

European Journal of Neurology

Volumn 19, Issue 10, 2012, Pages 1300-1304

  Pappa, T ^a   Vemmos, K ^a   Mantzou, E ^a   Savvari, P ^a   Stamatelopoulos, K ^a   Alevizaki, M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cerebrovascular disease; Endogenous estradiol; Female; Stroke

Indexed keywords

ESTRADIOL;

AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RISK; STATISTICAL SIGNIFICANCE; STROKE; TERTIARY HEALTH CARE;

AGED; ESTRADIOL; FEMALE; HUMANS; POSTMENOPAUSE; RECOVERY OF FUNCTION; STROKE;

EID: 84866303620     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03714.x     Document Type: Article

References (26)

1. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen-replacement therapy after ischaemic stroke. N Engl J Med 2001; 345: 1243-1249.
2. Simon JA, Hsia J, Cauley JA, et al. Postmenopausal hormone therapy and risk of stroke: the Heart and Estrogen-progestin Replacement Study (HERS). Circulation 2001; 103: 638-642.
3. Anderson GL, Limacher M, Assaf AR, et al. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 29: 1701-1712.
4. Pappa T, Vemmos K, Saltiki K, Mantzou E, Stamatelopoulos K, Alevizaki M. Severity and outcome of acute stroke in women: relation to adrenal sex steroid levels. Metabolism 2012; 61: 84-91.
5. Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864-870.
6. Rankin J. Cerebral vascular accidents in patient over the age of 60. II. Prognosis. Scott Med J 1957; 2: 200-215.
7. Golden SH, Maguire A, Ding J, et al. Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol 2002; 155: 437-445.
8. Wildman RP, Colvin AB, Powell LH, et al. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008; 15: 414-421.
9. Jeon GH, Kim SH, Yun SC, Chae HD, Kim CH, Kang BM. Association between serum estradiol level and coronary artery calcification in postmenopausal women. Menopause 2010; 17: 902-907.
10. Ouyang P, Vaidya D, Dobs A, et al. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2009; 204: 255-261.
11. Krejza J, Mariak Z, Huba M, Wolczynski S, Lewko J. Effect of endogenous estrogen on blood flow through carotid arteries. Stroke 2001; 32: 30-36.
12. Li XP, Zhou Y, Zhao SP, Gao M, Zhou QC, Li YS. Effect of endogenous estrogen on endothelial function in women with coronary heart disease and its mechanism. Clin Chim Acta 2004; 339: 183-188.
13. Lambrinoudaki I, Christodoulakos G, Rizos D, et al. Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women. Eur J Endocrinol 2006; 154: 907-916.
14. Shelley JM, Green A, Smith AM, et al. Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Ann Epidemiol 1998; 8: 39-45.
15. Szmuilowicz ED, Adler GK, Ricchiuti V, Hopkins PN, Seely EW. Relationships between endogenous sex hormone concentrations and vascular function in postmenopausal women. J Clin Endocrin Metab 2007; 92: 4738-4741.
16. Barrett-Connor E, Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 1995; 311: 1193-1196.
17. Debing E, Peeters E, Duquet W, Poppe K, Velkeniers B, Van den Brande P. Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy. Eur J Endocrinol 2007; 156: 687-693.
18. Merz CN, Johnson BD, Berga SL, et al. Women's Ischaemia Syndrome Evaluation Study Group. Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE). Journal of Women's Health 2009; 18: 1315-1322.
19. Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA. Age at natural menopause and risk of ischaemic stroke: the Framingham heart study. Stroke 2009; 40: 1044-1049.
20. Lee JS, Yaffe K, Lui LY, et al. Study of Osteoporotic Fractures Group Prospective study of endogenous circulating estradiol and risk of stroke in older women. Arch Neurol 2010; 67: 195-201.
21. Bushnell CD, Samsa GP, Goldstein LB. Hormone replacement therapy and ischaemic stroke severity in women: a case-control study. Neurology 2001; 56: 1304-1307.
22. Maggio M, Ceda GP, Lauretani F, et al. Relationship between higher estradiol levels and 9-year mortality in older women: the Invecchiare in Chianti study. J Am Geriatr Soc 2009; 57: 1810-1815.
23. Maggio M, Ceda GP, De Cicco G, et al. Acute changes in circulating hormones in older patients with impaired ventricular function undergoing on-pump coronary artery bypass grafting. J Endocrinol Invest 2005; 28: 711-719.
24. Purohit A, Reed MJ. Regulation of estrogen synthesis in postmenopausal women. Steroids 2002; 67: 979-983.
25. Störk S, Bots ML, Grobbee DE, van der Schouw YT. Endogenous sex hormones and C-reactive protein in healthy postmenopausal women. J Intern Med 2008; 264: 245-253.
26. Maggio M, Ceda GP, Lauretani F, et al. SHBG, sex hormones, and inflammatory markers in older women. J Clin Endocrin Metab 2011; 96: 1053-1059.